Compounds > 3-chloro-4-benzoyloxyphenylacetic acid
Page last updated: 2024-12-07

3-chloro-4-benzoyloxyphenylacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID91676
CHEMBL ID4303431
SCHEMBL ID3950358
MeSH IDM0081186

Synonyms (21)

Synonym
4-benzyloxy-3-chlorophenylacetic acid
benzofenac
3-chloro-4-(phenylmethoxy)benzeneacetic acid
(3-chloro-4-(phenylmethoxy)phenyl)acetic acid
kyselina 3-chlor-4-benzyloxyfenyloctova [czech]
3-chloro-4-benzyloxyphenylacetic acid
acetic acid, (4-(benzyloxy)-3-chlorophenyl)-
einecs 262-396-3
brn 2814595
3-chloro-4-benzoyloxyphenylacetic acid
vufb9682
benzeneacetic acid, 3-chloro-4-(phenylmethoxy)-
60736-70-1
2-(3-chloro-4-phenylmethoxyphenyl)acetic acid
kyselina 3-chlor-4-benzyloxyfenyloctova
SCHEMBL3950358
DTXSID20209553
[3-chloro-4-(phenylmethoxy)phenyl]acetic acid
[4-(benzyloxy)-3-chlorophenyl]acetic acid
FT-0729838
CHEMBL4303431
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (93.75)18.7374
1990's1 (6.25)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.43 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
phenacetin
Saridon: contains phenacetin, caffeine, propyphenazone & pyrithyldione		2.3720acetamides;
aromatic ether		cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug
nitrobenzene
nitrobenzene : A nitroarene consisting of benzene carrying a single nitro substituent. An industrial chemical used widely in the production of aniline.		2.3720nitroarene;
nitrobenzenes
phenylhydrazine
[no description available]		1.9710phenylhydrazinesxenobiotic
vufb 16066
flobufen: antirheumatic drug		1.9710
ConditionIndicatedRelationship StrengthStudiesTrials
Polyarthritis
[description not available]		02.3620
Adjuvant Arthritis
[description not available]		02.3620
Arthritis
Acute or chronic inflammation of JOINTS.		02.3620
Anasarca
[description not available]		01.9510
Edema
Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.		01.9510
Anemia, Hemolytic, Acquired
[description not available]		01.9710
Anemia, Hemolytic
A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).		01.9710
Adverse Drug Event
[description not available]		02.3720
Anemia
A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.		01.9710
Drug-Related Side Effects and Adverse Reactions
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.		02.3720